| Conditional distribution modeling as an alternative method for covariates simulation: comparison with joint multivariate normal and bootstrap techniques G Smania, EN Jonsson CPT: pharmacometrics & systems pharmacology 10 (4), 330-339, 2021 | 12 | 2021 |
| Model‐based assessment of alternative study designs in pediatric trials. Part II: Bayesian approaches G Smania, P Baiardi, A Ceci, M Cella, P Magni CPT: pharmacometrics & systems pharmacology 5 (8), 402-410, 2016 | 12 | 2016 |
| Translating QT interval prolongation from conscious dogs to humans VFS Dubois, G Smania, H Yu, R Graf, ASY Chain, M Danhof, ... British Journal of Clinical Pharmacology 83 (2), 349-362, 2017 | 11 | 2017 |
| Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3 A Bauer, S Friberg-Hietala, G Smania, M Wolfsegger Journal of Blood Medicine, 399-411, 2023 | 1 | 2023 |
| Pharmacokinetic analysis of levodopa and carbidopa following subcutaneous infusion: A population pharmacokinetics model (2019) T Birnberg, G Smania, M Bjornsson, N Jonsson, R Case, S Oren, L Adar, ... Neurology 96 (15 Supplement), 2021 | 1 | 2021 |
| Translational model-based approach to assist the dose-range selection of an antibody-drug conjugate entering Phase I P Mazzei, G Smania, C Piana, P Magni, M Binaschi, M Bigioni, G Merlino, ... PAGE Meeting, 2017 | 1 | 2017 |
| Model-based comparison of alternative study designs in pediatric trials G Smania, P Baiardi, M Cella, P Magni Part II: Bayesian approaches. CPT Pharmacometrics Syst. Pharmacol.(submitted), 2015 | 1 | 2015 |
| Population pharmacokinetics of levodopa and carbidopa following subcutaneous infusion T Birnberg, L Adar, G Smania, M Bjornsson, N Jonsson, R Case, ... Parkinsonism & Related Disorders 113, 2023 | | 2023 |
| Pharmacokinetic analysis of levodopa and carbidopa following subcutaneous infusion: A population pharmacokinetics model T Birnberg, G Smania, M Bjornsson, N Jonsson, R Case, S Oren, L Adar, ... EUROPEAN JOURNAL OF NEUROLOGY 28, 235-235, 2021 | | 2021 |
| Assessment of rVWF Pharmacokinetics in Overweight and Obese VWD Patients Using a Population Pharmacokinetic Model SA Hale, A Bauer, G Smania, S Friberg-Hietala, MJ Wolfsegger Blood 136, 7-8, 2020 | | 2020 |
| Population pharmacokinetic analysis of levodopa and carbidopa after subcutaneous administration with and without adjunct oral therapy T Birnberg, G Smania, M Bjornsson, N Jonsson, R Case, S Oren, L Adar, ... MOVEMENT DISORDERS 35, S389-S389, 2020 | | 2020 |
| Il modeling matematico, l'estrapolazione ei disegni di studio alternativi come strumenti per agevolare lo sviluppo pediatrico dei farmaci G Smania Università degli studi di Pavia, 2017 | | 2017 |
| The role of modelling and simulation in the paediatric investigation plan of a xanthine oxidase inhibitor for tumor lysis syndrome prevention G Smania, P Mazzei, C Piana, S Baldini, C Simonelli, A Capriati, ... PAGE Meeting, 2017 | | 2017 |
| A model-based approach to extrapolate drug-drug interactions from rats to humans C Piana, P Mazzei, G Smania, P Magni, A Lecci, A Capriati, A Pellacani PAGE Meeting, 2017 | | 2017 |
| GRIP List of principles to be considered when evaluating extrapolation approach from adult data G Smania, C Olivier, C Barker, P Baiardi, A Ceci, A Saint-Raymond, ... HEALTH, 261060, 2015 | | 2015 |
| Clinical trial simulations as a tool to investigate innovative study designs in paediatric trials G Smania, M Cella, P Baiardi, P Magni Congresso nazionale di Bioingegneria 2014-Atti, M-51/1-3, 2014 | | 2014 |
| Conditional distribution modeling for covariates simulation using classification and regression trees methods G Smania, EN Jonsson | | |
| Investigating the identifiability of one-stage IVIVC population models for extended-release dosage forms S Zannoni, A Brekkan, G Smania | | |
